DISSEMINATION: Ifakara scientist shares findings at national health forum
Ifakara Health Institute research scientist Kamaka Kassim presented findings of his latest study on antimalaria herbal remedy at the 39th Annual Sc…
Ifakara Health Institute research scientist Kamaka Kassim presented findings of his latest study on antimalaria herbal remedy at the 39th Annual Sc…
A donation of assorted items, worth TZS 8 million, was given to three primary schools within Chalinze district, Tanzania. The donation, from the Sw…
The Shinda Malaria project which is being implemented by Ifakara Health Institute hosted a microscopy recertification training exercise in Dar for …
Ifakara Health Institute researchers implementing the Global Effort on COVID-19 (GECO) project, on December 19, 2022, met with stakeholders to disc…
Ifakara Health Institute and partners are current testing a new and more effective malaria vaccine known as “R21”. The trial – at…
An Ifakara Health Institute work conducted by seasoned social scientist, Dr. Sally Mtenga, and colleagues was featured at the global COVID Circle C…
The NEST360 team met with health stakeholders in Dar es Salaam from December 1-2, 2022 to discuss the program’s implementation progress in Ta…
The U.S. President's Malaria Initiative (PMI) Coordinator, Dr. David Walton, on December 7th 2022, visited the Ifakara Health Institute Laborat…
Ifakara Health Institute Chief Executive Director, Dr. Honorati Masanja and USAID Tanzania Acquisition Officer Representative (AOR) Ms. Naomi Serba…
This month, Ifakara Health Institute scientist, Dr. Samson Kiware, hosted Dr. Amelia Bertozzi-Villa, a disease modeler from the Institute for Disea…